Harmony Biosciences Holdings annual operating margin
2019
2020
2021
2022
2023
2024
2025
Harmony Biosciences Holdings Operating Margin Growth & History (HRMY)
Harmony Biosciences Holdings's operating margin was 24.00% for fiscal 2025.
View full Harmony Biosciences Holdings company overviewHarmony Biosciences Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 24.00% | −2.69 pp |
| 2024 | 2024-12-31 | 26.70% | −6.29 pp |
| 2023 | 2023-12-31 | 32.99% | +5.54 pp |
| 2022 | 2022-12-31 | 27.45% | −1.21 pp |
| 2021 | 2021-12-31 | 28.66% | +18.02 pp |
| 2020 | 2020-12-31 | 10.63% | +2444.39 pp |
| 2019 | 2019-12-31 | −2,433.76% | — |
Harmony Biosciences Holdings quarterly operating margin
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 34.18% | +10.15 pp |
| Q1 2026 | 2026-03-31 | 17.31% | −13.13 pp |
| Q4 2025 | 2025-12-31 | 15.82% | −11.87 pp |
| Q3 2025 | 2025-09-30 | 27.35% | −5.82 pp |
| Q2 2025 | 2025-06-30 | 24.03% | +11.67 pp |
| Q1 2025 | 2025-03-31 | 30.45% | −3.21 pp |
| Q4 2024 | 2024-12-31 | 27.69% | +3.82 pp |
| Q3 2024 | 2024-09-30 | 33.17% | −7.08 pp |
| Q2 2024 | 2024-06-30 | 12.36% | −22.59 pp |
| Q1 2024 | 2024-03-31 | 33.65% | −0.28 pp |
| Q4 2023 | 2023-12-31 | 23.87% | −13.24 pp |
| Q3 2023 | 2023-09-30 | 40.25% | +30.10 pp |
| Q2 2023 | 2023-06-30 | 34.95% | +4.00 pp |
| Q1 2023 | 2023-03-31 | 33.93% | +1.63 pp |
| Q4 2022 | 2022-12-31 | 37.11% | +5.72 pp |
| Q3 2022 | 2022-09-30 | 10.15% | −15.92 pp |
| Q2 2022 | 2022-06-30 | 30.94% | −0.64 pp |
| Q1 2022 | 2022-03-31 | 32.30% | +7.95 pp |
| Q4 2021 | 2021-12-31 | 31.39% | +15.57 pp |
| Q3 2021 | 2021-09-30 | 26.08% | +3.32 pp |
| Q2 2021 | 2021-06-30 | 31.58% | +12.35 pp |
| Q1 2021 | 2021-03-31 | 24.35% | +72.79 pp |
| Q4 2020 | 2020-12-31 | 15.82% | — |
| Q3 2020 | 2020-09-30 | 22.76% | — |
| Q2 2020 | 2020-06-30 | 19.23% | — |
| Q1 2020 | 2020-03-31 | −48.43% | — |
Harmony Biosciences Holdings operating margin trends
Over the last five reported fiscal years, Harmony Biosciences Holdings's operating margin increased from 10.63% to 24.00%, a change of +13.37 percentage points. The latest reported quarter, Q2 2026, shows 34.18%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Harmony Biosciences Holdings filings at SEC.gov ↗